JP4965130B2 - 乾式直打速崩壊性錠剤 - Google Patents

乾式直打速崩壊性錠剤 Download PDF

Info

Publication number
JP4965130B2
JP4965130B2 JP2006017401A JP2006017401A JP4965130B2 JP 4965130 B2 JP4965130 B2 JP 4965130B2 JP 2006017401 A JP2006017401 A JP 2006017401A JP 2006017401 A JP2006017401 A JP 2006017401A JP 4965130 B2 JP4965130 B2 JP 4965130B2
Authority
JP
Japan
Prior art keywords
dry
disintegrating tablet
tablet
sodium
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2006017401A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007197357A5 (OSRAM
JP2007197357A (ja
Inventor
美佐 立田
哲 佐久間
逸見 榎本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Priority to JP2006017401A priority Critical patent/JP4965130B2/ja
Priority to PCT/JP2007/051156 priority patent/WO2007086457A1/ja
Priority to CN200780003393XA priority patent/CN101374503B/zh
Priority to KR1020087019484A priority patent/KR101386022B1/ko
Publication of JP2007197357A publication Critical patent/JP2007197357A/ja
Publication of JP2007197357A5 publication Critical patent/JP2007197357A5/ja
Application granted granted Critical
Publication of JP4965130B2 publication Critical patent/JP4965130B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2006017401A 2006-01-26 2006-01-26 乾式直打速崩壊性錠剤 Expired - Fee Related JP4965130B2 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2006017401A JP4965130B2 (ja) 2006-01-26 2006-01-26 乾式直打速崩壊性錠剤
PCT/JP2007/051156 WO2007086457A1 (ja) 2006-01-26 2007-01-25 乾式直打速崩壊性錠剤
CN200780003393XA CN101374503B (zh) 2006-01-26 2007-01-25 干式直压速崩性片剂
KR1020087019484A KR101386022B1 (ko) 2006-01-26 2007-01-25 건식 직타 속붕괴성 정제

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006017401A JP4965130B2 (ja) 2006-01-26 2006-01-26 乾式直打速崩壊性錠剤

Publications (3)

Publication Number Publication Date
JP2007197357A JP2007197357A (ja) 2007-08-09
JP2007197357A5 JP2007197357A5 (OSRAM) 2009-03-12
JP4965130B2 true JP4965130B2 (ja) 2012-07-04

Family

ID=38309245

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006017401A Expired - Fee Related JP4965130B2 (ja) 2006-01-26 2006-01-26 乾式直打速崩壊性錠剤

Country Status (4)

Country Link
JP (1) JP4965130B2 (OSRAM)
KR (1) KR101386022B1 (OSRAM)
CN (1) CN101374503B (OSRAM)
WO (1) WO2007086457A1 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023547736A (ja) * 2020-11-06 2023-11-13 マイラン ラボラトリーズ エルティーディー メロキシカム含有医薬組成物

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
KR101592620B1 (ko) 2008-10-08 2016-02-05 도쿠리츠교세이호진 노교간쿄기쥬츠겐큐쇼 유해 물질 흡착 성형체
US9795568B2 (en) * 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
JP5810819B2 (ja) * 2011-10-14 2015-11-11 ライオン株式会社 積層錠
JP5945191B2 (ja) * 2012-08-09 2016-07-05 株式会社ファンケル 口腔内速崩錠
JP6092672B2 (ja) * 2013-03-21 2017-03-08 株式会社ファンケル 口腔内速崩壊性錠剤
JP6266891B2 (ja) * 2013-03-29 2018-01-24 株式会社ロッテ 口腔内洗浄用組成物
CN103417512B (zh) * 2013-08-20 2015-08-12 吉林显锋科技制药有限公司 一种阿莫西林胶囊剂及其制备方法
US11786471B2 (en) * 2016-07-11 2023-10-17 Wuhan Ll Science And Technology Development Co. Ltd. Complex disintegrant system for oral solid preparation and oral solid preparation comprising said complex disintegrant system
CN107970219A (zh) * 2017-12-27 2018-05-01 佛山市南海东方澳龙制药有限公司 宠物用美洛昔康片及其制备方法和应用
JP7348703B2 (ja) * 2019-06-28 2023-09-21 エスエス製薬株式会社 メロキシカム含有造粒物
JP2023019148A (ja) * 2021-07-28 2023-02-09 エスエス製薬株式会社 一般用医薬品
JP2023019149A (ja) * 2021-07-28 2023-02-09 エスエス製薬株式会社 錠剤
CN114806602A (zh) * 2022-05-05 2022-07-29 朱贵远 一种聚丙烯酸钠防溅制剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009985A1 (en) * 1997-08-27 1999-03-04 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
NZ502990A (en) * 1997-08-27 2002-02-01 Hexal Ag Pharmaceutical compositions of meloxicam with improved solubility and bioavailability
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
EP1161941A4 (en) * 1999-03-15 2002-08-28 Kaken Pharma Co Ltd QUICKLY DISMANTLING TABLETS AND METHOD FOR THE PRODUCTION THEREOF
JP3435664B2 (ja) * 1999-12-08 2003-08-11 ヤンセンファーマ株式会社 口腔内速崩壊型錠剤及びその製造方法
EP1250921A1 (en) * 2001-04-21 2002-10-23 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Fast disintegrating meloxicam tablet
JP2006514119A (ja) * 2003-02-12 2006-04-27 アール アンド ピー コリア カンパニー リミテッド 溶解率が向上した難溶性薬剤の溶媒系
JP2005306770A (ja) * 2004-04-21 2005-11-04 Toa Eiyo Ltd 口腔内速崩壊型製剤及びその製造方法
WO2005123040A1 (ja) * 2004-06-22 2005-12-29 Shionogi & Co., Ltd. 口腔内速崩壊錠

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023547736A (ja) * 2020-11-06 2023-11-13 マイラン ラボラトリーズ エルティーディー メロキシカム含有医薬組成物

Also Published As

Publication number Publication date
KR20080108227A (ko) 2008-12-12
KR101386022B1 (ko) 2014-04-16
CN101374503B (zh) 2012-09-05
WO2007086457A1 (ja) 2007-08-02
CN101374503A (zh) 2009-02-25
JP2007197357A (ja) 2007-08-09

Similar Documents

Publication Publication Date Title
CN101374503B (zh) 干式直压速崩性片剂
JP4801255B2 (ja) 沸騰性酸−塩基対を含有する製薬学的組成物
JP5296456B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP4740740B2 (ja) 薬物含有粒子および該粒子を含む固形製剤
KR20100121509A (ko) 구강 내 붕괴정
JP5342028B2 (ja) 口腔内崩壊錠
JP2017141299A (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP2010270110A (ja) ネオテームを含有する経口製剤
JP2011513194A (ja) 口腔内崩壊錠
JP2005132801A (ja) 口腔内崩壊錠
JP2010241760A (ja) 不快な味の軽減された口腔内速崩壊錠及びその製造方法
JP5978335B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
KR20110007065A (ko) 구강내 붕괴정 및 그 제조 방법
JP5168712B2 (ja) ナテグリニド含有製剤
JP7250305B2 (ja) メマンチン又はその薬物学的に許容される塩を含む医薬組成物及びその製造方法
JP6151413B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP5714652B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
AU2020215141B2 (en) Orodispersible tablet
JP5226732B2 (ja) 催眠用圧縮成型製剤
JP2017052755A (ja) 固形製剤
JP2010053048A (ja) 苦味が緩和されたイルベサルタン含有医薬組成物
US20240091367A1 (en) Orally disintegrating palatable formulations of drotaverine and method of preparation thereof
JP2021113237A (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP2018168185A (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP2019202981A (ja) レボセチリジン固形製剤

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20081007

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20081202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20081202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090123

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090123

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120306

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120327

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120329

R150 Certificate of patent or registration of utility model

Ref document number: 4965130

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150406

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S802 Written request for registration of partial abandonment of right

Free format text: JAPANESE INTERMEDIATE CODE: R311802

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees